News

Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b “X-TOLE” Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion Leaders

Echosens Partners with Veteran-Owned Fidelis: Announces Addition of FibroScan to US Defense Logistics Agency’s Medical Equipment ECAT

Improves Access to Non-invasive Liver Assessment, Provides Early Detection and Monitoring of Chronic Liver Disease WALTHAM, Mass.--(BUSINESS WIRE)--#ECAT--Echosens, a high-technology...

error: Content is protected !!